Transposon insertion in three additional genes, clpA, glnK, and fabF1, resulted in weaker, but robust suppression of the attenuation of Orsay virus leading to infection of 34%, 28%, and 17% of the population respectively (Figure 5B, Figure 5—figure supplement 1). The gene discussed is TBX22; the disease is infection.